CD8A and neoplasm: As would be expected from a complement response (69), RT-mediated complement activation increased NK1.1+ (natural killer cells) but not NKp46+ (invariant NK-T cell) cell populations which likely served to enhance anti-tumor response of CD8+ T cells.